Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online July 2, 2022.
Article Versions
- You are currently viewing an Earlier version of this article (July 2, 2022 - 02:31).
- View the most recent version of this article
Copyright & Usage
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Author Information
- Franziska Marie Heydenreich1,*,
- Bianca Plouffe2,
- Aurelien Rizk3,
- Dalibor Milic4,
- Joris Zhou5,
- Billy Breton5,
- Christian Le Gouill6,
- Asuka Inoue7,
- Michel Bouvier8,*, and
- Dmitry Veprintsev9,*
- 1Structural Studies, MRC Laboratory of Molecular Biology, United Kingdom
- 2Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, United Kingdom
- 3InterAx Biotech AG, Switzerland
- 4Department of Structural and Computational Biology, University of Vienna, Austria
- 5Institute for Research in Immunology and Cancer, University of Montreal, Canada
- 6University of Montreal, Canada
- 7Tohoku University, Japan
- 8Department of Biochemistry and Molec ular Medicine, University of Montreal, Canada
- 9School of Life Sciences, University of Nottingham, United Kingdom
- ↵* Corresponding Author:
Dmitry Veprintsev, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, N/A, United Kingdom. E-mail: dmitry.veprintsev{at}nottingham.ac.uk - * Corresponding Author; email: michel.bouvier{at}umontreal.ca
- * Corresponding Author; email: dmitry.veprintsev{at}nottingham.ac.uk